XML 84 R61.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Reporting (Tables)
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
(In millions)
SeedCrop ProtectionTotal
As of and for the Year Ended December 31, 2025   
Net sales$9,898 $7,503 $17,401 
Segment operating EBITDA2,636 1,350 3,986 
Depreciation and amortization780 423 1,203 
Purchases of property, plant and equipment377 214 591 
As of and for the Year Ended December 31, 2024   
Net sales$9,545 $7,363 $16,908 
Segment operating EBITDA2,219 1,272 3,491 
Depreciation and amortization805 422 1,227 
Purchases of property, plant and equipment365 232 597 
As of and for the Year Ended December 31, 2023
Net sales$9,472 $7,754 $17,226 
Segment operating EBITDA2,117 1,374 3,491 
Depreciation and amortization814 397 1,211 
Purchases of property, plant and equipment332 263 595 

Reconciliation of Segment Profitability
(In millions)SeedCrop ProtectionTotal
For the Year Ended December 31, 2025
Net sales$9,898 $7,503 $17,401 
Cost of goods sold4,533 4,585 9,118 
Other expenses 1
2,729 1,568 4,297 
Segment operating EBITDA$2,636 $1,350 $3,986 
(In millions)SeedCrop ProtectionTotal
For the Year Ended December 31, 2024
Net sales$9,545 $7,363 $16,908 
Cost of goods sold4,876 4,636 9,512 
Other expenses 1
2,450 1,455 3,905 
Segment operating EBITDA$2,219 $1,272 $3,491 
(In millions)SeedCrop ProtectionTotal
For the Year Ended December 31, 2023
Net sales$9,472 $7,754 $17,226 
Cost of goods sold4,982 4,913 9,895 
Other expenses 1
2,373 1,467 3,840 
Segment operating EBITDA$2,117 $1,374 $3,491 
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Income (loss) from continuing operations after income taxes to segment operating EBITDAFor the Year Ended December 31,
(In millions)202520242023
Income (loss) from continuing operations after income taxes$1,204 $863 $941 
Provision for (benefit from) income taxes on continuing operations484 412 152 
Income (loss) from continuing operations before income taxes$1,688 $1,275 $1,093 
Depreciation and amortization1,203 1,227 1,211 
Interest income(136)(132)(283)
Interest expense180 233 233 
Exchange (gains) losses - net181 284 397 
Non-operating (benefits) costs - net39 174 151 
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges— — — 
Significant items658 315 579 
Separation costs35 — — 
Corporate expenses138 115 110 
Segment operating EBITDA$3,986 $3,491 $3,491 
Schedule of Additional Segment Details [Table Text Block]
(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 2025
Restructuring and asset related charges - net 1
$(4)$(135)$(7)$(146)
Bayer resolution 2
(610)— — (610)
Gain (loss) on sale of business, assets and equity investments 3,4
— 37 — 37 
AltEn facility remediation charges 5
(37)— — (37)
Insurance proceeds 6
— 98 — 98 
Total$(651)$— $(7)$(658)

(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 2024
Restructuring and asset related charges - net 1
$(55)$(142)$(91)$(288)
Gain (loss) on sale of business, assets and equity investments 4
4 3 — 7 
Inventory write-offs 4
2 — — 2 
Insurance proceeds 6
— 71 — 71 
Estimated settlement expense 7
— (101)— (101)
Acquisition-related costs 8
— (6)— (6)
Total$(49)$(175)$(91)$(315)
(In millions)SeedCrop ProtectionCorporateTotal
For the Year Ended December 31, 2023
Restructuring and asset related charges - net 1
$(86)$(228)$(22)$(336)
Gain (loss) on sale of business, assets and equity investments 4
4 10 — 14 
Inventory write-offs 4
(7)— — (7)
Spare parts write-off 3
— (12)— (12)
Estimated settlement expense 7
— (204)— (204)
Acquisition-related costs 8
— (45)— (45)
AltEn facility remediation charges 5
(10)— — (10)
Employee Retention Credit— 3 — 3 
Seed sale associated with Russia Exit 4,9
18 — — 18 
Total$(81)$(476)$(22)$(579)
1.Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information.
2.Consists of a charge relating to the resolution of litigation with Bayer. See Note 15 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for additional information.
3.Incremental gains (losses) associated with activities related to the Crop Protection Operations Strategy Restructuring Program. Within gain (loss) on sale of business, assets and equity investments, a $23 million benefit was recorded for the year ended December 31, 2025.
4.Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions. Within gain (loss) on sale of business, assets and equity investments, such benefits are $14 million, $7 million and $14 million for the years ended December 31, 2025, 2024 and 2023, respectively.
5.Relates to a charge to increase the remediation accrual at the AltEn facility relating to Corteva's estimated voluntary contribution to the solid waste and wastewater remedial action plans. See Note 15 - Commitments and Contingent Liabilities, to the Consolidated Financial Statements, for additional information.
6.Includes proceeds received related to prior significant items.
7.Consists of estimated Lorsban® related charges.
8.Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up.
9.Includes a benefit of $18 million for the year ended December 31, 2023, relating to the sale of seeds already under production in Russia when the decision to exit the country was made and that the company was contractually required to purchase. It consists of $71 million of net sales and $53 million of cost of goods sold for the year ended December 31, 2023.